Cooper Robin D G - Net Worth and Insider Trading

Cooper Robin D G Net Worth

The estimated net worth of Cooper Robin D G is at least $19,737 dollars as of 2024-11-10. Cooper Robin D G is the Sr. V.P. Pharmaceutical Scs. of Rigel Pharmaceuticals Inc and owns about 900 shares of Rigel Pharmaceuticals Inc (RIGL) stock worth over $19,737. Details can be seen in Cooper Robin D G's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cooper Robin D G has not made any transactions after 2005-12-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Cooper Robin D G

To

Cooper Robin D G Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cooper Robin D G owns 1 companies in total, including Rigel Pharmaceuticals Inc (RIGL) .

Click here to see the complete history of Cooper Robin D G’s form 4 insider trades.

Insider Ownership Summary of Cooper Robin D G

Ticker Comapny Transaction Date Type of Owner
RIGL Rigel Pharmaceuticals Inc 2005-12-07 Sr. V.P. Pharmaceutical Scs.

Cooper Robin D G Latest Holdings Summary

Cooper Robin D G currently owns a total of 1 stock. Cooper Robin D G owns 900 shares of Rigel Pharmaceuticals Inc (RIGL) as of December 7, 2005, with a value of $19,737.

Latest Holdings of Cooper Robin D G

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RIGL Rigel Pharmaceuticals Inc 2005-12-07 900 21.93 19,737

Holding Weightings of Cooper Robin D G


Cooper Robin D G Form 4 Trading Tracker

According to the SEC Form 4 filings, Cooper Robin D G has made a total of 0 transactions in Rigel Pharmaceuticals Inc (RIGL) over the past 5 years. The most-recent trade in Rigel Pharmaceuticals Inc is the acquisition of 100 shares on December 7, 2005, which cost Cooper Robin D G around $8,120.

Insider Trading History of Cooper Robin D G

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Cooper Robin D G Trading Performance

GuruFocus tracks the stock performance after each of Cooper Robin D G's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cooper Robin D G is 44.61%. GuruFocus also compares Cooper Robin D G's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cooper Robin D G within 3 months outperforms 4 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Cooper Robin D G's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Cooper Robin D G

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
3 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 14.97 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 13.71 LIMIT LIMIT LIMIT LIMIT LIMIT

Cooper Robin D G Ownership Network

Ownership Network List of Cooper Robin D G

No Data

Ownership Network Relation of Cooper Robin D G

Insider Network Chart

Cooper Robin D G Owned Company Details

What does Rigel Pharmaceuticals Inc do?

Who are the key executives at Rigel Pharmaceuticals Inc?

Cooper Robin D G is the Sr. V.P. Pharmaceutical Scs. of Rigel Pharmaceuticals Inc. Other key executives at Rigel Pharmaceuticals Inc include Sr VP of Bus Dev and Com Ops Raul R Rodriguez , EVP & Chief Financial Officer Dean L Schorno , and EVP & Chief Commercial Officer David A Santos .

Rigel Pharmaceuticals Inc (RIGL) Insider Trades Summary

Over the past 18 months, Cooper Robin D G made no insider transaction in Rigel Pharmaceuticals Inc (RIGL). Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 52,894 shares made by Raul R Rodriguez , a net sale of 14,519 shares made by David A Santos , and a net sale of 12,628 shares made by Dean L Schorno .

In summary, during the past 3 months, insiders sold 0 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,004 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 8,004 shares.

Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Rigel Pharmaceuticals Inc Insider Transactions

No Available Data

Cooper Robin D G Mailing Address

Above is the net worth, insider trading, and ownership report for Cooper Robin D G. You might contact Cooper Robin D G via mailing address: 1180 Veterans Blvd, South San Francisco Ca 94080.